RxSight Inc (RXST)
44.83
-0.22
(-0.49%)
USD |
NASDAQ |
Nov 22, 16:00
44.85
+0.02
(+0.04%)
After-Hours: 20:00
RxSight Cash from Operations (Quarterly): 0.65M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.65M |
| June 30, 2024 | -4.027M |
| March 31, 2024 | -9.309M |
| December 31, 2023 | -8.301M |
| September 30, 2023 | -7.982M |
| June 30, 2023 | -7.546M |
| March 31, 2023 | -17.76M |
| December 31, 2022 | -13.85M |
| September 30, 2022 | -15.19M |
| June 30, 2022 | -14.82M |
| Date | Value |
|---|---|
| March 31, 2022 | -14.98M |
| December 31, 2021 | -8.722M |
| September 30, 2021 | -13.76M |
| June 30, 2021 | -11.98M |
| March 31, 2021 | -10.25M |
| December 31, 2020 | -8.227M |
| September 30, 2020 | -6.948M |
| June 30, 2020 | -7.81M |
| March 31, 2020 | -12.22M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-17.76M
Minimum
Mar 2023
0.65M
Maximum
Sep 2024
-10.16M
Average
-9.309M
Median
Mar 2024
Cash from Operations (Quarterly) Benchmarks
| Tandem Diabetes Care Inc | 26.78M |
| PROCEPT BioRobotics Corp | -18.80M |
| Perspective Therapeutics Inc | 3.366M |
| Xtant Medical Holdings Inc | -1.718M |
| Catheter Precision Inc | -2.768M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -9.26M |
| Cash from Financing (Quarterly) | 0.878M |
| Free Cash Flow | -27.17M |
| Free Cash Flow Per Share (Quarterly) | -0.0114 |
| Free Cash Flow to Equity (Quarterly) | -0.453M |
| Free Cash Flow to Firm (Quarterly) | -0.453M |
| Free Cash Flow Yield | -1.60% |